Proteonomix Inc. (PROT)
OTC
Closed
Oct 6, 2026
Day's Range
0.00010052 wk Range
0.000100Overview - PROT - Proteonomix Inc.
Key Statistics
Valuation
Enterprise Value
310.73K
Price / Sales (TTM)
‪0.03‬
EV / EBITDA
‪-0.09‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-14,544.45%‬
Return on Assets
‪-50.98%‬
Ownership
Shares Outstanding
7.91M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪-43.69‬
50-Day Avg
‪0.00010‬
200-Day Avg
‪0.00010‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Monthly
Market Cap - PROT - Proteonomix Inc.
Peers - PROT - Proteonomix Inc.
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
- PROTOTCProteonomix Inc.791Market Cap+0.00%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- ARGNFOTCargenx SE58.55BMarket Cap+10.95%52-week change35.71P/E (Trailing)‪32.26%‬Profit Margin
- BEIGFOTCBeiGene Ltd.32.27BMarket Cap+27.32%52-week change51.04P/E (Trailing)‪10.69%‬Profit Margin
- AKESFOTCAkeso Inc.12.43BMarket Cap-38.39%52-week change25.67P/E (Trailing)‪-28.03%‬Profit Margin
- AAVXFOTCAbivax SA12.13BMarket Cap+38.06%52-week change-28.78P/E (Trailing)‪0.00%‬Profit Margin
- BCHMYOTCBachem Holding AG7.49BMarket Cap+22.42%52-week change39.58P/E (Trailing)‪21.02%‬Profit Margin
- AKBLFOTCALK-Abelló A/S6.92BMarket Cap+6.61%52-week change33.55P/E (Trailing)‪19.85%‬Profit Margin
Profile Summary - PROT - Proteonomix Inc.
About
Proteonomix Inc. is a biotechnology company specializing in cutting-edge advancements within the field of proteomics. This asset plays a pivotal role in biomedical research and therapeutic development by focusing on the discovery and commercialization of protein-based therapies. Proteonomix Inc.'s primary function is…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
